Bitget Launches Private Copy Trading for CFD

VICTORIA, Seychelles - Tuesday, 04. August 2026

(GLOBE NEWSWIRE) -- Bitget, the world’s largest Universal Exchange (UEX), has introduced Private Copy Trading for its CFD platform, giving professional traders the tools to build invitation-only trading communities while maintaining greater control over strategy distribution. The feature reflects the growing evolution of copy trading from a public discovery tool into a community-driven business model.

As copy trading has evolved, many successful traders have expanded beyond the platform itself, building dedicated communities across Telegram, Discord, X, and other social channels. These communities often become the primary way traders share market insights and cultivate long-term relationships. Rather than making every strategy publicly available, many now reserve their highest-conviction trades as exclusive benefits for members of those communities.

The feature introduces flexibility to community management, allowing traders to generate multiple invitation links for different communities or marketing channels, monitor conversion performance across each source, manage follower capacity independently, and remove followers when necessary. Public and private copy trading projects can also operate in parallel, enabling traders to grow a public audience while maintaining exclusive communities for selected users.

"As leaders of crypto copy trading, we’ve been one of the few players to evolve this segment" said Gracy Chen, CEO of Bitget. "Traders trust data and transparent copy-trading helps in collective growth, another tier added to this is private copy trading, providing professional traders with more flexibility in sharing strategies."

The invitation-only model also helps protect proprietary trading strategies by limiting visibility to approved participants rather than opening trading activity publicly. For traders focused on client acquisition, optional registration requirements tied to invitation links provide a more targeted way to onboard new users while measuring the effectiveness of different promotional channels.

Bitget pioneered copy trading as one of the first major exchanges to make professional trading strategies accessible to a broader audience. The launch reflects a broader evolution in the creator economy surrounding trading. As professional traders increasingly build independent brands and communities, copy trading platforms are evolving from simple discovery tools into infrastructure that supports audience management, client acquisition, and long-term community growth. Private Copy Trading extends Bitget's copy trading ecosystem to meet those changing needs.

To find out more, visit here.

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 500+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships such as MotoGP™. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.

For more information, visit: Website | X | Telegram | LinkedIn | Discord

For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c75a0757-6ad4-4e1b-a9b9-fbd222b85dba

New 3D Flash Memory Technology from Kioxia and Sandisk Achieves Industry’s Highest Bit Density for QLC NAND

 10th-generation QLC 3D flash memory represents a major leap forward for AI storage architectures, cloud platforms, and data‑intensive innovations

 

(BUSINESS WIRE)--Future of Memory and Storage Conference (FMS) – Kioxia Corporation, a subsidiary of Kioxia Holdings Corporation (TOKYO: 285A) and Sandisk Corporation (Nasdaq: SNDK) today unveiled their next-generation Quad-Level-Cell (QLC) 3D flash memory technology, which delivers up to 60% increase in bit density compared to their 8th-generation, surpassing 37 Gb/mm² and setting the industry benchmark1 for bit density, performance and power efficiency.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804147821/en/

Leveraging the companies’ revolutionary CMOS directly Bonded to Array (CBA) technology2 which fabricates CMOS logic and the memory array on separate wafers before bonding them together with high-precision wafer-to-wafer alignment, the new generation improves read and write bandwidth compared to the 8th-generation 3D flash memory and becomes the industry’s first QLC 3D flash memory technology to reach a 4.8 Gb/s 3 interface.

Additional interface enhancements improve I/O data-out transfer power efficiency. These large power efficiency upgrades directly address the power and cooling challenges of modern AI and cloud infrastructure.

Chief Technology Officer at Kioxia, Hideshi Miyajima, said, “As AI continues to underpin the advancement of society, its applications are expanding from generative AI to agent-based and physical AI, while the use of data is becoming increasingly diverse and sophisticated. QLC technology enables the efficient storage of rapidly expanding data volumes, helping deliver greater performance and scalability for AI systems. Kioxia will accelerate development toward the commercialization of its 10th-generation flash memory products incorporating QLC technology.”

Chief Technology Officer at Sandisk, Alper Ilkbahar, said, "As AI training, inference, and hyperscale datacenter workloads drive unprecedented growth in data generation, the storage industry faces increasing pressure to deliver greater capacity, higher performance, and improved energy efficiency. By redefining the performance and efficiency envelope of QLC NAND, our 10th-generation QLC 3D flash memory delivers simultaneous gains in density, bandwidth, and energy efficiency and establishes a new paradigm for high‑capacity flash storage to provide a scalable foundation for next‑generation infrastructure applications.”

Key 10th-genaration QLC 3D flash memory technology highlights include:

332‑layer architecture and optimized floorplan design deliver up to 60% increase in bit density, achieving >37 Gb/mm² compared to the 8th-generation.

4.8 Gb/s 3 NAND interface enabled by Toggle DDR6.0 and the Separate Command Address (SCA) protocol to unlock the full potential of fast interface.

CMOS directly Bonded to Array (CBA) architecture enhances density scaling, performance, and manufacturing efficiency.

Power‑Isolated Low‑Tapped Termination (PI‑LTT) improves I/O data-out transfer power efficiency.

As of August 4, 2026, based on Kioxia and Sandisk survey.

Technology wherein each CMOS wafer and cell array wafer are manufactured separately in their optimized condition and then bonded together.

1Gb/s is calculated as 1,000,000,000 bits/second. This value is obtained under our specific test environment, and may vary depending on use conditions.

About Kioxia

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with “memory” by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, automotive systems, data centers and generative AI systems.

About Sandisk

Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, YouTube. Join TeamSandisk on Instagram.

Sandisk and the Sandisk logo are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the US and/or other countries. All other marks are the property of their respective owners. Product specifications subject to change without notice. Pictures shown may vary from actual products.

© 2026 Sandisk Corporation or its affiliates. All rights reserved.

Company names, product names and service names may be trademarks of their respective companies.

Forward Looking Statement

This press release contains forward-looking statements within the meaning of U.S. federal securities laws, including statements regarding expectations for the performance, capabilities, improved power efficiency, bit density and scalability of Sandisk Corporation’s and Kioxia Corporation’s BiCS10 QLC technology; the expected growth of AI training, inference, and hyperscale datacenter workloads and the resulting demand for growth in data generation; the anticipated benefits of the BiCS10 QLC architecture for modern AI, cloud infrastructure, hyperscale data centers, and enterprise storage applications; and the anticipated industry significance and competitive positioning of the technology. These forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Key risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements include: adverse changes in global or regional economic conditions, including the impact of evolving trade policies, tariff regimes and trade wars; volatility in demand for Sandisk’s products; pricing trends and fluctuations in average selling prices; exposure to execution, financial and market risks due to long-term agreements; inflation; changes in interest rates and a potential economic recession; the impact of business and market conditions; the impact of competitive products and pricing; the development and introduction of products based on new technologies and management of technology transitions; risks associated with strategic initiatives, including restructurings, acquisitions, divestitures, cost saving measures and joint ventures; risks related to product defects; difficulties or delays in manufacturing or other supply chain disruptions; reliance on strategic relationships with key partners, including Kioxia Corporation; the attraction, retention and development of skilled management and technical talent; risks associated with the use of artificial intelligence in business operations; changes to relationships with key customers or consolidation among the customer base; compromise, damage or interruption from cybersecurity incidents or other data system security risks; reliance on intellectual property; fluctuations in currency exchange rates; actions by competitors; risks associated with compliance with changing legal and regulatory requirements; and other risks and uncertainties listed in Sandisk’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K filed with the SEC on August 21, 2025 and Quarterly Report on Form 10-Q filed with the SEC on May 1, 2026, to which your attention is directed. You should not place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Sandisk undertakes no obligation to update or revise these forward-looking statements to reflect new information or events, except as required by law.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260804147821/en/

Permalink

https://aetoswire.com/en/news/4082026565999

Contacts

Sandisk Contacts:

Investors: investors@sandisk.com

Media: mediainquiries@sandisk.com

Kioxia Contact:

Media: kioxia-hd-pr@kioxia.com

 

WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership

BOSTON - Tuesday, 04. August 2026

The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership.

(BUSINESS WIRE)--WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control.

The Natural Cycles app, a Class II medical device, uses biomarker data, including temperature and heart rate data, to identify fertile and non-fertile days, helping users prevent pregnancy without hormones while also providing fertility insights. Beyond birth control, the app also supports users through pregnancy planning, pregnancy, postpartum, and perimenopause with dedicated modes tailored to each stage of their reproductive journey.

This integration and exclusive offer advance the efforts of WHOOP in women’s health by combining continuous physiological data with clinically validated fertility technology. Women are one of the fastest-growing segments of WHOOP members, with membership growing 111% year over year. As demand grows for personalized health insights and non-hormonal reproductive health options, this integration gives WHOOP members a more seamless way to understand fertility alongside the recovery, sleep, and health insights already available through WHOOP.

"This partnership represents a commitment to supporting women's health through clinically-backed, actionable data," said Dr. Ami Bhatt, WHOOP Chief Medical Officer. "By integrating with the NC° app, we are providing our members with a seamless way to access personalized reproductive health insights, expanding WHOOP beyond performance into everyday health."

"At Natural Cycles, we're committed to making digital contraception as seamless as possible for our users," said Dr. Magda Armbruster, VP of Product at Natural Cycles. "Integrating with WHOOP removes friction from the experience by allowing members to use the wearable they already rely on to automatically capture overnight skin temperature used by the NC° app to determine daily fertility status. It's another step toward making hormone-free birth control fit more naturally into everyday life."

Membership Benefits:

A 12-month subscription to the NC° app included with any WHOOP membership for members new to Natural Cycles.

Automatic overnight skin temperature sharing with the NC° app through compatible WHOOP devices.

Daily fertility status inside the world's only FDA-cleared digital birth control app.

Features designed by Natural Cycles° to support women throughout the reproductive journey—from birth control and pregnancy planning to pregnancy, postpartum, and perimenopause.

The integration is currently available for users with WHOOP MG and 5.0 devices. WHOOP and Natural Cycles° remain committed to the highest standards of privacy and data security, ensuring that sensitive health information is managed with the utmost care.

To learn more about WHOOP, please visit whoop.com. To access visuals, please visit the Digital Press Kit.

About WHOOP

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.

Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $950 million in venture capital, ships to 56 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.

About Natural Cycles°

Founded in 2013 by physicists Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles is a leading women's digital health company dedicated to transforming how women understand and manage their reproductive health. The company developed the world's first FDA-cleared digital method of birth control, delivered through an app and powered by a proprietary algorithm that interprets biomarker data, including body temperature, to provide personalized cycle insights and a daily fertility status. The NC° Birth Control app is an FDA-cleared Class II medical device with six FDA clearances and has also received regulatory authorizations in Europe, Canada, Brazil, Australia, Singapore, and South Korea.

With a single subscription, the Natural Cycles app offers five dedicated modes—NC° Birth Control, NC° Plan Pregnancy, NC° Follow Pregnancy, NC° Postpartum, and NC° Perimenopause—supporting women throughout their reproductive lives. Trusted by more than six million registered users worldwide and backed by 30 peer-reviewed studies, Natural Cycles continues to pioneer science-driven, non-invasive innovations that expand access to personalized reproductive health tools and empower women to take control of their reproductive health.

Learn more at Naturalcycles.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260804399367/en/

Permalink

https://www.aetoswire.com/en/news/54582456

Contacts

 

Press Contact

Jack Taylor Worldwide

Whoop@jacktaylorpr.com

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care

 SAN DIEGO - Tuesday, 04. August 2026 AETOSWire Print 

(BUSINESS WIRE)--LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3

KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5

The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The first FDA approval of a menin inhibitor for relapsed or refractory acute leukemia with a KMT2A translocation established clinical validation for this emerging drug class.7 As menin inhibitor programs move into frontline and combination studies, there is an increasing need for sensitive molecular testing that can accurately characterize KMT2Ar, quantify deep molecular response, and track response durability over time.

Standardized MRD Testing for Global Clinical Development

LabPMM’s new test targets the most common KMT2A partner fusion genes in AML and ALL,8 aligning the assay with the KMT2A biology central to many current menin inhibitor development programs. The test provides a quantitative result reported as the percentage of KMT2Ar relative to a housekeeping gene. The assay supports disease characterization and longitudinal MRD monitoring with sensitivity down to 0.005% and a turnaround time in as little as 48 hours.9 This launch expands Invivoscribe’s comprehensive myeloid testing portfolio, which includes globally standardized molecular assay kits and LabPMM services for screening and MRD monitoring of FLT3, NPM1, KMT2Ar, as well as AML MRD assessment by multiparametric flow cytometry. Together, these integrated capabilities enable drug developers and healthcare providers to monitor disease burden over time with unprecedented sensitivity and accuracy.

“Menin inhibitors are creating important new possibilities for patients with KMT2A-rearranged leukemia, but continued development requires a partner that can deliver highly sensitive, standardized molecular data across clinical programs and geographies,” said Jeff Miller, CEO and CSO of Invivoscribe. “By making KMT2A MRD testing available through LabPMM, we are helping clinicians and biopharmaceutical partners measure meaningful responses earlier, monitor their durability, and ultimately improve patient care.”

Together, Invivoscribe and LabPMM provide an integrated global ecosystem of standardized MRD testing, regulatory expertise, and companion diagnostic capabilities. Highly sensitive MRD testing can help define molecular response depth, evaluate response durability, support patient stratification, and accelerate trials when used as surrogate endpoints. By generating consistent molecular data across global clinical programs, this integrated approach helps sponsors make earlier, more informed decisions and reduce development risk from early clinical studies through regulatory submission, approval, and commercialization.

Healthcare providers and biopharmaceutical sponsors developing menin inhibitors for acute leukemia or other immunotherapies can contact Invivoscribe to discuss our global testing programs. Visit www.invivoscribe.com or contact inquiry@invivoscribe.com

About Invivoscribe

Invivoscribe® is a global, vertically integrated biotechnology company dedicated to Improving Lives with Precision Diagnostics®. For over thirty years, Invivoscribe has improved the quality of healthcare worldwide by providing high-quality standardized reagents, tests, and bioinformatics tools to advance the field of precision medicine. Invivoscribe has a successful track record of partnerships with pharmaceutical companies interested in clinical trial testing via our global lab network located in the U.S., Germany, Japan, and China, and in developing and commercializing companion diagnostics, with rigorous expertise in both regulatory and laboratory services. Providing distributable kits, as well as clinical trial services through its globally located clinical lab subsidiaries, LabPMM®, Invivoscribe is an ideal partner from diagnostic development through clinical trials, regulatory submissions, and commercialization.

References

Dillon, L. et al. JAMA Oncol. 2024;10;(8):1104-1110. https://doi.org/10.1001/jamaoncol.2024.0985

Levis, M., et al. Blood. 2025;145(19):2138-2148 https://doi.org/10.1182/blood.2024025154

Hourigan CS, et al. Blood. 2025;145(19)2105-2106. https://doi.org/10.1182/blood.2024028105

Petersen, L. et al. J Mol Diag. 2025;27(10)989-1002. https://doi.org/10.1016/j.jmoldx.2025.06.007

Yin, L. et al. Cancer Med. 2024;13(20):e70326. https://doi.org/10.1002/cam4.70326

Al-Ali, R. et al. Bone Marrow Transplant. 2025;61:222-224. https://doi.org/10.1038/s41409-025-02757-1

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-revumenib-relapsed-or-refractory-acute-leukemia-KMT2A-translocation

Additional KMT2A partner fusion genes will be added in early 2027 further expanding ALL coverage.

MRD results from our KMT2A, FLT3-ITD, and NPM1 assays can be reported in as little as 48 hours, although standard turnaround time is 7-10 business days.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803738654/en/

Permalink

https://www.aetoswire.com/en/news/54582770

Contacts

 

inquiry@invivoscribe.com

1-866-623-8105

Kioxia to Showcase CXL™ Compatible Memory Expansion Module KIOXIA XL1 Series for AI Workloads

 TOKYO - Monday, 03. August 2026

(BUSINESS WIRE) -- Kioxia Corporation, a world leader in memory solutions, today announced that it will exhibit the KIOXIA XL1 series, a Compute Express Link™ (CXL™) compatible memory expansion module, at the Kioxia booth at FMS: the Future of Memory and Storage, taking place August 4 - 6 in Santa Clara, CA. The product features KIOXIA XL-FLASH™, a low-latency and high-performance flash memory technology that enables flash memory, traditionally used for storage applications, to also be utilized as a memory expansion solution. In addition, it is being designed and developed to support the growing volume of memory-intensive AI applications. Evaluation samples are scheduled to be shipped to industry ecosystem collaborators in August 2026.

In recent years, the growing number of AI workloads has significantly increased memory demand in data centers, creating serious challenges such as capacity shortages and rising costs. In response to this important market need, Kioxia is targeting an innovative memory expansion solution for hyperscale environments. The KIOXIA XL1 series memory expansion module combines low-latency, high-performance XL-FLASH™ with a CXL™ interface and improves DRAM utilization efficiency by placing less frequently accessed data on the module. It bridges the performance and cost gap between conventional DRAM and SSDs, enabling memory expansion for demanding AI applications.

Note: The sample drives are for evaluation purposes only. Some functions may not have been fully tested, and specifications are subject to change.

Related Link:

https://www.kioxia.com/en-jp/business/memory/xlflash.html

Compute Express Link and CXL are trademarks of Compute Express Link Consortium, Inc.

Other company names, product names and service names may be trademarks of third-party companies.

About Kioxia

Kioxia is a world leader in memory solutions, dedicated to the development, production and sale of flash memory and solid-state drives (SSDs). In April 2017, its predecessor Toshiba Memory was spun off from Toshiba Corporation, the company that invented NAND flash memory in 1987. Kioxia is committed to uplifting the world with “memory” by offering products, services and systems that create choice for customers and memory-based value for society. Kioxia's innovative 3D flash memory technology, BiCS FLASH™, is shaping the future of storage in high-density applications, including advanced smartphones, PCs, SSDs, automotive systems, data centers and generative AI systems.

*Information in this document, including product prices and specifications, content of services and contact information, is correct on the date of the announcement but is subject to change without prior notice.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803920975/en/

Permalink

https://www.aetoswire.com/en/news/0308202656581

Contacts

Media Inquiries:

Kioxia Corporation

Promotion Management Division

Satoshi Shindo

Tel: +81-3-6478-2404

NIQ Returns to IFA 2026 to Lead Industry Conversations on Growth, Innovation, AI and Consumer Transformation

 Exclusive insights, executive thought leadership and industry dialogue at the IFA Retail Leaders Summit and NIQ Business Breakfast

(BUSINESS WIRE) -- As the Official Global Insights Partner of IFA Berlin 2026, NIQ (NYSE: NIQ) will continue to play a leading role shaping industry discussions , bringing together data, AI-driven intelligence, and human insight to illuminate the forces reshaping growth, innovation, and consumer behavior. Through executive keynotes, panel discussions, exclusive market intelligence, and strategic customer engagements (including participation in the IFA Retail Leaders Summit, the fourth NIQ Business Breakfast, and a dedicated SMB-focused event) NIQ will help translate rapid market change into actionable opportunity for the global technology ecosystem.

Under this year’s IFA theme, “The Future Is Now,” NIQ will provide timely perspectives on the forces redefining consumer technology, home appliances, and retail—from AI-driven innovation and evolving shopper expectations to omnichannel transformation and emerging growth opportunities.

As brands and retailers navigate economic uncertainty, shifting purchase behavior, and increasing price sensitivity, NIQ’s latest market data highlights both the challenges and opportunities facing the sector. While Tech and Durables markets remain under pressure in some regions, growth continues to emerge across key European markets, reinforcing the importance of innovation, agility, and data-driven decision-making.

“IFA is where the future of the industry takes shape,” said Perry James, SVP, Global Tech & Durables, NIQ. “We’re entering a new era where data, AI, and consumer behavior are converging, and the rules of growth are being rewritten in real time. The question isn’t whether the industry will change, but who will have the intelligence to lead it. NIQ is bringing insights designed to help the industry move from analysis to action.”

IFA 2026 Event Programme: AI, Innovation and the Future of Growth

NIQ will bring its latest AI-driven insights and market intelligence to IFA 2026 through a series of high-impact engagements designed to explore the forces reshaping technology and retail.

IFA Retail Leaders Summit (3 September)

NIQ will join senior retail and technology executives to discuss how AI, data and evolving consumer behaviors are transforming the future of commerce. In a keynote session, NIQ will share insights into the forces reshaping the Tech & Durables industry, drawing on global market intelligence and consumer trends to highlight how businesses can drive sustainable growth through AI-powered decision-making, omnichannel strategies and next-generation retail models in an increasingly complex marketplace. More information here.

The Intelligence Edge: How Emerging Tech Brands Compete and Win (4 September)

An SMB-focused session on where growth is emerging, how challengers are winning share, and what distribution shifts reveal about broader market transformation—followed by a networking reception with NIQ experts. More information here.

NIQ Business Breakfast: Reset 2026—Disruption, New Players and the Future of the Tech Industry (5 September)

NIQ’s Business Breakfast will bring together industry leaders to examine a market in transition, where social commerce, marketplaces, D2C channels, and AI-powered experiences are reshaping how consumers discover and buy. The discussion will focus on how brands and retailers can adapt—through emerging commerce ecosystems, platform-agnostic journeys, and stronger control of the customer experience in an AI-driven world. More information here.

FAQs

1. What is NIQ’s role at IFA 2026?

NIQ is the Official Global Insights Partner of IFA Berlin 2026 and will lead industry conversations through executive keynotes, panel discussions, and exclusive market intelligence focused on growth, AI-driven innovation, and consumer transformation.

2. What insights will NIQ share at IFA 2026?

NIQ will provide AI-driven and data-powered insights on the forces reshaping consumer technology, home appliances, and retail—including omnichannel commerce, evolving shopper behavior, retail media, and emerging growth opportunities.

3. Which events will NIQ participate in at IFA 2026?

NIQ will participate in the IFA Retail Leaders Summit (3 September) and host the Intelligence Edge SMB-focused session (4 September) as well as NIQ Business Breakfast (5 September), each addressing different dimensions of AI, innovation, and market transformation.

4. How is AI influencing the technology and retail sectors according to NIQ?

AI is accelerating change across the ecosystem, reshaping how consumers discover and purchase products, enabling more advanced decision-making, and creating new opportunities for brands and retailers to drive growth through data and intelligence.

About NIQ

NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.

With operations in more than 90 countries, NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next.

For more information, please visit www.niq.com.

Forward Looking Statement

This press release includes forward-looking statements that reflect NIQ’s current expectations and projections about future market trends and consumer behavior. These statements are based on available information and reasonable assumptions but are subject to risks and uncertainties that could cause actual results to differ. NIQ does not undertake to update these statements, except as required by law.

Disclaimer

All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

© 2026 Nielsen Consumer LLC. All Rights Reserved.

NIQ-GENERAL

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260803586988/en/

Permalink

https://www.aetoswire.com/en/news/0308202656582

Contacts

Julia Mayer, julia.mayer@nielseniq.com

 

First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC

 WINDSOR, Conn. - 

(BUSINESS WIRE) -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*.

“As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.”

The engagement highlights the breadth and scalability of SS&C’s global service model. Leveraging SS&C’s integrated investment operations solution, First Plus will modernize its investment operations and bolster cross-jurisdictional compliance across Asia. The solution will streamline the process for front-office teams to trade and manage portfolio exposures and manage investor accounting and reconciliation. SS&C will also provide transfer agency services in Thailand, supporting FPAM’s investor servicing and recordkeeping. FPAM will also gain access to SS&C’s integrated automation capabilities to optimize and streamline operations.

“We are thrilled to further our relationship with First Plus as their business continues to grow,” said Damien Barry, Head of Asia Pacific, Africa & Middle East for SS&C Global Investor & Distribution Solutions. “As asset management continues to globalize and offer new and complex fund vehicles, we are seeing an increased demand for cross-border operations and compliance support. We look forward to working with First Plus to streamline and integrate their workflows through our scalable global ecosystem, so the First Plus team can focus on growth and investor experiences.”

*As of June 30, 2026

About First Plus Asset Management

Based in Singapore, First Plus Asset Management Pte. Ltd. is a licensed asset management firm focused on the Asia-Pacific market. The firm holds a Capital Markets Services (CMS) Fund Management License from the Monetary Authority of Singapore (MAS) and has been recognized with key regulatory qualifications, including Qualified Foreign Institutional Investor (QFII) status granted by the China Securities Regulatory Commission (CSRC) and approval for Bond Connect by the People’s Bank of China (PBOC).

First Plus Asset Management (Thailand) Company Limited, an affiliated entity within the group, is licensed by Thailand’s Ministry of Finance to manage public mutual funds, private funds, and provident funds. It’s also recognized by the CSRC as a QFII.

Combining global perspectives with deep regional expertise, the First Plus group delivers sustainable, long-term growth through its capabilities in structured credit, quantamental strategies, and other diversified investment solutions.

About SS&C Technologies

SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world's largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.

Additional information about SS&C (Nasdaq: SSNC) is available at www.ssctech.com.

Follow SS&C on X, LinkedIn and Facebook.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260802033024/en/

Permalink

https://www.aetoswire.com/en/news/0308202656578

Contacts

Brian Schell | Chief Financial Officer, SS&C Technologies

Tel: +1-816-642-0915 | E-mail: InvestorRelations@sscinc.com

Justine Stone | Investor Relations, SS&C Technologies

Tel: +1-212-367-4705 | E-mail: InvestorRelations@sscinc.com

Media Contacts

Madison Gallo

Prosek Partners

Email: pro-SSC@prosek.com